Listen "ASCO 2024 Melanoma Updates for Surgical Oncologists"
Episode Synopsis
Please listen in as Drs. Piltin, van Akkooi, and Hyngstrom discuss relevant clinical trial presentations from ASCO 2024 annual meeting and their impressions on the implications for surgical oncologists. Abstracts results discussed include the neoadjuvant NADINA and PIVOTAL trials as well as an initial report on upfront TIL therapy for stage IV patients.
ZARZA We are Zarza, the prestigious firm behind major projects in information technology.